Systematic Metabolic Profiling of Mice with Dextran Sulfate Sodium-Induced Colitis

References

• Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982–1992. doi:10.1097/MIB.0000000000000392
   PubMed Web of Science ®Google Scholar
• Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621. doi:10.1146/annurev-immunol-030409-101225
   PubMed Web of Science ®Google Scholar
• Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99(6):1051–1062. doi:10.1016/j.suc.2019.08.001
   PubMed Web of Science ®Google Scholar
• De Preter V, Verbeke K. Metabolomics as a diagnostic tool in gastroenterology. World J Gastrointest Pharmacol Ther. 2013;4(4):97–107. doi:10.4292/wjgpt.v4.i4.97
   PubMedGoogle Scholar
• Baranska A, Mujagic Z, Smolinska A, et al. Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach. Aliment Pharmacol Ther. 2016;44(1):45–56. doi:10.1111/apt.13654
   PubMed Web of Science ®Google Scholar
• Shankar V, Reo NV, Paliy O. Simultaneous fecal microbial and metabolite profiling enables accurate classification of pediatric irritable bowel syndrome. Microbiome. 2015;3:73. doi:10.1186/s40168-015-0139-9
   PubMed Web of Science ®Google Scholar
• Keshteli AH, Madsen KL, Mandal R, et al. Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers. Aliment Pharmacol Ther. 2019;49(6):723–732. doi:10.1111/apt.15141
   PubMed Web of Science ®Google Scholar
• Liao Z, Zhang S, Liu W, et al. LC-MS-based metabolomics analysis of Berberine treatment in ulcerative colitis rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1133:121848. doi:10.1016/j.jchromb.2019.121848
   PubMed Web of Science ®Google Scholar
• Jiang P, Guo Y, Dang R, et al. Salvianolic acid B protects against lipopolysaccharide-induced behavioral deficits and neuroinflammatory response: involvement of autophagy and NLRP3 inflammasome. J Neuroinflammation. 2017;14(1):239. doi:10.1186/s12974-017-1013-4
   PubMedGoogle Scholar
• Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–2078. doi:10.1056/NEJMra0804647
   PubMed Web of Science ®Google Scholar
• Davis VW, Bathe OF, Schiller DE, et al. Metabolomics and surgical oncology: potential role for small molecule biomarkers. J Surg Oncol. 2011;103(5):451–459. doi:10.1002/jso.21831
   PubMed Web of Science ®Google Scholar
• Manna SK, Tanaka N, Krausz KW, et al. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology. 2014;146(5):1313–1324. doi:10.1053/j.gastro.2014.01.017
   PubMed Web of Science ®Google Scholar
• Nishiumi S, Izumi Y, Yoshida M. Alterations in docosahexaenoic acid-related lipid cascades in inflammatory bowel disease model mice. Dig Dis Sci. 2018;63(6):1485–1496. doi:10.1007/s10620-018-5025-4
   PubMed Web of Science ®Google Scholar
• Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–958. doi:10.1001/jama.2015.0954
   PubMed Web of Science ®Google Scholar
• Christgen SL, Becker DF. Role of proline in pathogen and host interactions. Antioxid Redox Signal. 2019;30(4):683–709. doi:10.1089/ars.2017.7335
   PubMed Web of Science ®Google Scholar
• Tsune I, Ikejima K, Hirose M, et al. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology. 2003;125(3):775–785. doi:10.1016/S0016-5085(03)01067-9
   PubMed Web of Science ®Google Scholar
• Dawiskiba T, Deja S, Mulak A, et al. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol. 2014;20(1):163–174. doi:10.3748/wjg.v20.i1.163
   PubMed Web of Science ®Google Scholar
• Sperringer JE, Addington A, Hutson SM. Branched-chain amino acids and brain metabolism. Neurochem Res. 2017;42(6):1697–1709. doi:10.1007/s11064-017-2261-5
   PubMed Web of Science ®Google Scholar
• White PJ, Newgard CB. Branched-chain amino acids in disease. Science. 2019;363(6427):582–583. doi:10.1126/science.aav0558
   PubMed Web of Science ®Google Scholar
• Brocker C, Thompson DC, Vasiliou V. The role of hyperosmotic stress in inflammation and disease. Biomol Concepts. 2012;3(4):345–364. doi:10.1515/bmc-2012-0001
   PubMedGoogle Scholar
• Morgenstern I, Raijmakers MTM, Peters WHM, et al. Homocysteine, cysteine, and glutathione in human colonic mucosa elevated levels of homocysteine in patients with inflammatory bowel disease. Dig Dis Sci. 2003;48(10):2083–2090. doi:10.1023/A:1026338812708
   PubMed Web of Science ®Google Scholar
• Lih-Brody L, Powell SR, Collier KP, et al. Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease. Dig Dis Sci. 1996;41:2078–2086. doi:10.1007/BF02093613
   PubMed Web of Science ®Google Scholar
• Geng C, Guo Y, Wang C, et al. Comprehensive evaluation of lipopolysaccharide-induced changes in rats based on metabolomics. J Inflamm Res. 2020;13:477–486. doi:10.2147/JIR.S266012
   PubMed Web of Science ®Google Scholar
• Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem. 2007;113(4–5):234–258. doi:10.1080/13813450701661198
   PubMedGoogle Scholar
• Ballatori N, Krance SM, Notenboom S, et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem. 2009;390(3):191–214. doi:10.1515/BC.2009.033
   PubMed Web of Science ®Google Scholar
• Sturniolo GC, Mestriner C, Lecis PE, et al. Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scan J Gastroenterol. 1998;33:644–649. doi:10.1080/00365529850171936
   PubMed Web of Science ®Google Scholar
• Tüzün A, Erdil A, Inal V, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem. 2002;35(7):569–572. doi:10.1016/S0009-9120(02)00361-2
   PubMed Web of Science ®Google Scholar
• Zhou Q, Verne GN. NMDA receptors and colitis: basic science and clinical implications. Rev Analg. 2008;10(1):33–43. doi:10.3727/154296108783994013
   PubMedGoogle Scholar
• Rodriguez-Nogales A, Algieri F, De Matteis L, et al. Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats. Int J Nanomed. 2016;11:5945–5958. doi:10.2147/IJN.S116479
   PubMed Web of Science ®Google Scholar
• Schicho R, Nazyrova A, Shaykhutdinov R, et al. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by 1H NMR spectroscopy. J Proteome Res. 2010;9(12):6265–6273. doi:10.1021/pr100547y
   PubMed Web of Science ®Google Scholar
• Ghia JE, Li N, Wang H, et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology. 2009;137(5):1649–1660. doi:10.1053/j.gastro.2009.08.041
   PubMed Web of Science ®Google Scholar
• Crittenden S, Cheyne A, Adams A, et al. Purine metabolism controls innate lymphoid cell function and protects against intestinal injury. Immunol Cell Biol. 2018;96(10):1049–1059. doi:10.1111/imcb.12167
   PubMed Web of Science ®Google Scholar
• Ooi M, Nishiumi S, Yoshie T, et al. GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis. Inflamm Res. 2011;60(9):831–840. doi:10.1007/s00011-011-0340-7
   PubMed Web of Science ®Google Scholar